- Home
- MHLD vs THTX Comparison
MHLD vs THTX Comparison
Compare MHLD & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHLD
- THTX
- Stock Information
- Founded
- MHLD 2007
- THTX 1993
- Country
- MHLD Bermuda
- THTX Canada
- Employees
- MHLD N/A
- THTX N/A
- Industry
- MHLD Property-Casualty Insurers
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- MHLD Finance
- THTX Health Care
- Exchange
- MHLD Nasdaq
- THTX Nasdaq
- Market Cap
- MHLD 96.4M
- THTX 93.3M
- IPO Year
- MHLD 2008
- THTX N/A
- Fundamental
- Price
- MHLD $0.87
- THTX $1.85
- Analyst Decision
- MHLD
- THTX Hold
- Analyst Count
- MHLD 0
- THTX 1
- Target Price
- MHLD N/A
- THTX N/A
- AVG Volume (30 Days)
- MHLD 129.2K
- THTX 89.0K
- Earning Date
- MHLD 03-11-2025
- THTX 04-09-2025
- Dividend Yield
- MHLD N/A
- THTX N/A
- EPS Growth
- MHLD N/A
- THTX N/A
- EPS
- MHLD N/A
- THTX N/A
- Revenue
- MHLD $89,074,000.00
- THTX $84,316,000.00
- Revenue This Year
- MHLD N/A
- THTX $5.78
- Revenue Next Year
- MHLD N/A
- THTX $2.47
- P/E Ratio
- MHLD N/A
- THTX N/A
- Revenue Growth
- MHLD 20.80
- THTX 5.75
- 52 Week Low
- MHLD $0.83
- THTX $1.08
- 52 Week High
- MHLD $2.27
- THTX $2.18
- Technical
- Relative Strength Index (RSI)
- MHLD 37.29
- THTX 58.80
- Support Level
- MHLD $0.85
- THTX $1.56
- Resistance Level
- MHLD $1.29
- THTX $2.06
- Average True Range (ATR)
- MHLD 0.08
- THTX 0.14
- MACD
- MHLD 0.01
- THTX 0.04
- Stochastic Oscillator
- MHLD 17.43
- THTX 68.84
About MHLD Maiden Holdings Ltd.
Maiden Holdings Ltd provides reinsurance products and services to regional and specialty property and casualty insurers. The company operates in two segments: AmTrust Reinsurance and Diversified Reinsurance. The AmTrust Reinsurance segment provides products that cover workers' compensation, commercial package, commercial auto, and extended warranty. The Diversified Reinsurance segment provides small and midsize regional and specialty insurers with reinsurance capital products. Its revenues also include fee income earned from both its GLS business and IIS business as well as income generated from its investment portfolio.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.